Study summary · research use only
Mechanochemical coupling of MGF mediates periodontal regeneration
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This study (species not specified; combining in vivo and in vitro experiments and mathematical modeling) investigated whether mechano-growth factor (MGF), produced by periodontal ligament (PDL) tissue in response to mechanical stimulation, enhances PDL regeneration. The abstract reports that MGF produced under occlusion force enhanced PDL remodeling in vivo, and that in vitro experiments and modeling further supported a mechanical enhancement effect of MGF on PDL stem cell differentiation toward fibroblasts. The authors describe a mechanochemical coupling effect mediated by Fyn-FAK kinase signaling and the subsequent MAPK pathway, including ERK1/2 and p38 phosphorylation, as underlying this enhancement, and state that MGF-centered adjuvant treatment could be explored to optimize PDL remodeling, particularly for patients with weakened bite force or damaged periodontium.
Abstract
Clinical evidence shows that the mechanical stimulation obtained from occlusion could enhance periodontal ligament (PDL) remodeling. Mechano-growth factor (MGF) is a growth factor produced specifically following mechanical stimulus Here, we aim to investigate the mechanical enhancement potential and mechanism of the MGF in PDL regeneration. In vivo study found that MGF produced from the PDL under occlusion force could strongly enhance PDL remodeling. In vitro experiments and mathematical modeling further confirmed the mechanical enhancement effect of MGF for PDLSC differentiation toward fibroblasts. A mechanochemical coupling effect of MGF mediated the enhancement of mechanical effect, which was modulated by Fyn-FAK kinases signaling and subsequent MAPK pathway. Finally, enhanced PDL regeneration under the mechanochemical coupling of MGF and occlusal force was verified in vivo. There exists an additive mechanical effect of MGF mediated by Fyn-FAK crosstalk and subsequent ERK1/2 and p38 phosphorylation, which could be developed as an MGF-centered adjuvant treatment to optimize PDL remodeling, especially for patients with weakened bite force or destroyed periodontium.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.